H.R. 417 (109th): Medical Innovation Prize Act of 2005

Introduced:

Jan 26, 2005
109th Congress, 2005–2006

Status:
Died in a previous Congress

This bill was introduced on January 26, 2005, in a previous session of Congress, but was not enacted.

Sponsor:

Bernard “Bernie” Sanders
Representative for Vermont At Large
Independent

Text:

Read Text »
Last Updated: Jan 26, 2005
Length: 21 pages

About the bill

Full Title

To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.

Read CRS Summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 2210 (110th) was a re-introduction of this bill in a later Congress.

Referred to Committee
Last Action: Oct 19, 2007

What is a bill?

The “H.R.” in “H.R. 417” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jan 26, 2005

Details

Cosponsors
none
Committee Assignments
Health

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: